Advertisement

General Characteristics of the Cell-Drug System

  • A. J. Clark
Part of the Handbuch der Experimentellen Pharmakologie book series (HDBEP)

Abstract

The sizes of certain molecules, visible organisms, and ultra-microscopic viruses and phages are shown in Tables 1, 2 and 3. The measurements in these three tables are, for convenience, given in different units, but these can readily be transposed. (1 micron = 1000 milli-micra, 1 mμ = 10 A., 1 cubic micron = 109 cubic millimicra and 1 cu.mμ = 1000 cubic A.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hardy, W. B., and M. Nottage: Proc. roy. Soc. A. 118, 209 (1928).CrossRefGoogle Scholar
  2. 2.
    Reiner, L., C. S. Leonard and S. S. Chao: Arch. int. Pharmacodyn. 43, 186 (1932).Google Scholar
  3. 4.
    Herzberg, K.: Klin. Wschr. 15, 1665 (1936).CrossRefGoogle Scholar
  4. 5.
    Levaditi, C., M. Paic, J. Voet and D. Krassnoff: C. r. Soc. Biol. Paris 122, 354 (1936).Google Scholar
  5. 1.
    Landolt-Börnstein: Physikalisch-chemische Tabellen 1, 119. 5. Aufl. Berlin: Julius Springer 1923.Google Scholar
  6. 3.
    Langmuir, I.: Amer. chem. Soc. Abstr. 11, 2422 (1917).Google Scholar
  7. 4.
    Svedberg, T., and I.-B. Eriksson: Tab. Biol. Period. 5, 351 (1936).Google Scholar
  8. 5.
    Kunitz, M., M. L. Anson and J. H. Northrop: J. gen. Physiol. 11, 365 (1934).CrossRefGoogle Scholar
  9. 7.
    Stanley, W. M.: Science (N. Y.) 81, 644 (1935).CrossRefGoogle Scholar
  10. 1.
    Peters, R. A.: J. State Med. 37, 1 (1930).Google Scholar
  11. 2.
    Cameron, A. T.: Trans. roy. Soc. Canada, Sect. 5, 151 (1929).Google Scholar
  12. 3.
    Haldane, J. B. S.: Enzymes. London: Longman, Green and Co. 1930.Google Scholar
  13. 1.
    Warburg, O., and N. Christian: Biochem. Z. 266, 377 (1933).Google Scholar
  14. 2.
    Zeile, K.: Erg. Physiol. 35, 498 (1933).CrossRefGoogle Scholar
  15. 3.
    Warburg, O., and F. Kubowitz: Biochem. Z. 214, 5 (1929).Google Scholar
  16. 4.
    Kruse, W., and M. Fischer: Arch. f. Hyg. 113, 46 (1935).Google Scholar
  17. 5.
    Leitner, N.: Klin. Wschr. 8, 1952 (1929).CrossRefGoogle Scholar
  18. 6.
    Freundlich, H., and K. Söllner: Biochem. Z. 203, 1 (1928).Google Scholar
  19. 7.
    Reiner, L., C. S. Leonard and S. S. Chao: Arch. internat. Pharmacodynamie 43, 186 (1932).Google Scholar
  20. 8.
    Meninghetti, E.: Biochem. Z. 131, 38 (1922).Google Scholar
  21. 9.
    Ponder, E.: Proc. roy. Soc. B. 106, 543 (1930).CrossRefGoogle Scholar
  22. 10.
    Christophers, S. R.: Indian J. med. Res. 17, 54 (1929).Google Scholar
  23. 1.
    Marrack, J. R.: Med. Res. Counc. Spec. Rep. 194, 115 (1934).Google Scholar
  24. 2.
    Ottenberg, R., and F. A. Steenbuck: Proc. Soc. exper. Biol. a. Med. 21, 203 (1923).CrossRefGoogle Scholar
  25. 3.
    Straub, W.: Biochem. Z. 28, 392 (1910).Google Scholar
  26. 4.
    Clark, A. J.: The Mode of Action of Drugs on Cells, p. 16. London: Arnold and Co. 1933.Google Scholar
  27. 6.
    Armstrong, P. B.: J. of Physiol. 84, 20 (1935).Google Scholar
  28. 1.
    Erxleben, H.: Erg. Physiol. 37, 186 (1935).CrossRefGoogle Scholar
  29. 2.
    Hunt, Reid: Amer. J. Physiol. 45, 197 (1918).Google Scholar
  30. 3.
    Dale, H. H., and A. N. Richards: J. of Physiol. 52, 110 (1918).Google Scholar
  31. 4.
    Ellinger, Fr.: Quoted from W. Feldberg and E. Schilf: Histamin. Berlin: Julius Springer 1930.Google Scholar
  32. 5.
    Gremels, H.: Arch. f. exper. Path. 182, 1 (1936).CrossRefGoogle Scholar
  33. 6.
    Achutin, N.: Arch. f. exper. Path. 171, 668 (1933).CrossRefGoogle Scholar
  34. 7.
    Watanabe: Quoted from W. Feldberg and E. Schilf: Histamin, p. 175. Berlin: Julius Springer 1930.Google Scholar
  35. 8.
    Rothlin, E.: Biochem. Z. 111, 299 (1920).Google Scholar
  36. 9.
    Krogh, A.: J. Pharmacol. Baltimore 29, 177 (1926).Google Scholar
  37. 10.
    Ahlgren, G. A.: Klin. Wschr. 1, 667 (1924)CrossRefGoogle Scholar
  38. — Skand. Arch. Physiol. (Berl. u. Lpz.) 47, 271 (1926).CrossRefGoogle Scholar
  39. 11.
    Euler, U. von: Skand. Arch. Physiol. (Berl. u. Lpz.) 59, 123 (1930)CrossRefGoogle Scholar
  40. — Klin. Wschr. 12, 671 (1933).CrossRefGoogle Scholar
  41. 1.
    Kisch, B., and J. Leibwitz: Biochem. Z. 220, 97 (1930).Google Scholar
  42. 2.
    Myrhman, G.: Klin. Wschr. 11, 2139 (1932).CrossRefGoogle Scholar
  43. 3.
    Verebely, T. von: Klin. Wschr. 11, 1705 (1932).CrossRefGoogle Scholar
  44. 4.
    Büngeler, W.: Klin. Wschr. 12, 933 (1933).CrossRefGoogle Scholar
  45. 5.
    Clark, A. J.: The Mode of Action of Drugs on Cells. p. 25. London: Arnold and Co. 1933.Google Scholar
  46. 7.
    Haarmann, W.: Arch. f. exper. Path. 180, 167 (1936).CrossRefGoogle Scholar
  47. 8.
    Brinley, F. J.: Proc. Soc. exper. Biol. a. Med. 25, 305 (1928)CrossRefGoogle Scholar
  48. — J. gen. Physiol. 12, 201 (1928).PubMedCrossRefGoogle Scholar
  49. 9.
    Hiller, S.: Proc. Soc. exper. Biol. a. Med. 24, 427, 938 (1927).CrossRefGoogle Scholar
  50. 10.
    Marsland, D.: J. Cell. Comp. Physiol. 4, 9 (1934).CrossRefGoogle Scholar
  51. 11.
    Brinley, F. J.: Amer. J. Physiol. 85, 355 (1928).Google Scholar
  52. 1.
    Cook, R. P.: J. of Physiol. 62, 160 (1926).Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1937

Authors and Affiliations

  • A. J. Clark
    • 1
  1. 1.EdinburghUK

Personalised recommendations